Education
About Us
Working with TipRanks
Follow Us
Clinica Baviera (ES:CBAV)
:CBAV
CBAV Stock Chart & Stats
Day’s Range― - ―
52-Week Range€29.70 - €46.50
Previous CloseN/A
Volume285.00
Average Volume (3M)4.23K
Market Cap
€748.33M
Enterprise Value€631.13M
Total Cash (Recent Filing)€40.16M
Total Debt (Recent Filing)€8.94M
Price to Earnings (P/E)18.4
Beta0.42
Next Earnings
Nov 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 11, 2025Dividend Yield3.42%
Share Statistics
EPS (TTM)0.62
Shares Outstanding16,307,580
10 Day Avg. Volume2,961
30 Day Avg. Volume4,234
Financial Highlights & Ratios
PEG Ratio1.07
Price to Book (P/B)5.24
Price to Sales (P/S)1.93
P/FCF Ratio14.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€51.00Price Target Upside11.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Clinica Baviera News
CBAV FAQ
What was Clinica Baviera’s price range in the past 12 months?
Clinica Baviera lowest stock price was €29.70 and its highest was €46.50 in the past 12 months.
What is Clinica Baviera’s market cap?
Clinica Baviera’s market cap is €748.33M.
When is Clinica Baviera’s upcoming earnings report date?
Clinica Baviera’s upcoming earnings report date is Nov 06, 2025 which is in 68 days.
How were Clinica Baviera’s earnings last quarter?
Clinica Baviera released its earnings results on Jul 29, 2025. The company reported €0.621 earnings per share for the quarter, beating the consensus estimate of N/A by €0.621.
Is Clinica Baviera overvalued?
According to Wall Street analysts Clinica Baviera’s price is currently Undervalued.
Does Clinica Baviera pay dividends?
Clinica Baviera pays a Annually dividend of €1.57 which represents an annual dividend yield of 3.42%. See more information on Clinica Baviera dividends here
What is Clinica Baviera’s EPS estimate?
Clinica Baviera’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinica Baviera have?
Clinica Baviera has 16,307,580 shares outstanding.
What happened to Clinica Baviera’s price movement after its last earnings report?
Clinica Baviera reported an EPS of €0.621 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.882%.
Which hedge fund is a major shareholder of Clinica Baviera?
Currently, no hedge funds are holding shares in ES:CBAV
Clinica Baviera Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€51.00 (11.11% Upside)
€51.00 (11.11% Upside)
Insider Transactions
Sold Shares
Worth €91.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.60%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.77%
Trailing 12-Months
Company Description
Clinica Baviera
Clinica Baviera (CBAV) is a leading ophthalmology clinic specializing in vision correction treatments, including LASIK eye surgery, cataract surgery, and other refractive procedures. Established in Spain, the clinic has expanded its operations across several countries, providing high-quality eye care services. CBAV focuses on advanced technology and personalized patient care to deliver optimal results for those seeking to improve their vision.
Technical Analysis
Faes Farma
―
LABORATORIO REIG JOFRE
―
Naturhouse Health
―
PRIM, S.A.
―
Atrys Health SA
―
Ownership Overview
<0.01% Insiders
0.37%
Mutual Funds
― Other Institutional Investors
99.63% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---